Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Net Margin (2017 - 2025)

Historic Net Margin for Assembly Biosciences (ASMB) over the last 8 years, with Q3 2025 value amounting to 85.23%.

  • Assembly Biosciences' Net Margin rose 552000.0% to 85.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 103.65%, marking a year-over-year increase of 404100.0%. This contributed to the annual value of 140.87% for FY2024, which is 7139100.0% up from last year.
  • According to the latest figures from Q3 2025, Assembly Biosciences' Net Margin is 85.23%, which was up 552000.0% from 105.94% recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Net Margin peaked at 85.23% during Q3 2025, and registered a low of 300.66% during Q3 2021.
  • Its 4-year average for Net Margin is 145.22%, with a median of 140.44% in 2024.
  • Its Net Margin has fluctuated over the past 5 years, first plummeted by -2909800bps in 2021, then skyrocketed by 632900bps in 2025.
  • Assembly Biosciences' Net Margin (Quarter) stood at 300.66% in 2021, then surged by 49bps to 153.04% in 2023, then increased by 8bps to 140.48% in 2024, then skyrocketed by 39bps to 85.23% in 2025.
  • Its Net Margin was 85.23% in Q3 2025, compared to 105.94% in Q2 2025 and 93.62% in Q1 2025.